An interesting historical study found that inhibiting miR-7a activated mTOR signalling, which enhanced the proliferation of pancreatic islet cells in mice; the authors suggested that targeting the mir-7–mTOR axis may therefore have potential therapeutic value for treating diabetes [121]. The gene discussed is MTOR; the disease is diabetes mellitus.